Artificial Tears, Tear Lipids and Tear Film Dynamics
Status:
Not yet recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
Dry eye disease (DED) is pervasive with some reports estimating over 16 million adults
diagnosed in the United States. Currently, artificial tears remain an integral part of
managing dry eyes and are mainly used for symptomatic relief. Recent studies have shown there
may be therapeutic benefits with regular use of lipid-based artificial tears to improve the
structure of the tear film, which may improve tear film stability and provide relief of
symptoms. In this study the investigators propose to compare effects on the tear lipid film
and its dynamics between 3 lipid based artificial tears and a widely available non-lipid
based artificial tear.